Fig 1: Proposed model of the two waves of autophagy induced by PPRV via distinct pathways. PPRV induces a first transient wave of autophagy via a mechanism involving its cellular receptor NECTIN4 and an AKT-MTOR-dependent pathway. Soon after infection, new autophagic signalling is initiated that requires viral replication and protein expression. The IRGM-HSPA1A pathway is required for the second wave of autophagy induced by PPRV infection.
Fig 2: PPRV-H and NECTIN4 are sufficient to induce the first wave of autophagy via AKT and MTOR dephosphorylation. (A) His-tagged V, H and N were expressed in E. coli BL-21 and purified using Ni-NTA columns. The purified products were separated using SDS-PAGE and analyzed by immunoblotting with an anti-His antibody. (B) EECs were transfected with GFP-LC3 for 24 h and incubated with 100 ng/mL His-GST, His-V, His-H, or His-N for 1.5 h. Autophagy was monitored by evaluating the number of GFP+-LC3 vesicles per cell profile by confocal immunofluorescence microscopy. Scale bars, 20 μm. (C) Corresponding graph representing the numbers of GFP+-LC3 vesicles per cell profile in EECs pre-treated with His-GST, His-V, His-H, or His-N. (D) EECs were cultured in DMEM/F12 supplemented with 2% fetal bovine serum containing His-GST, His-V, His-H or His-N for 1.5 h and analyzed by immunoblotting with anti-LC3, anti-SQSTM1, anti-p-MTOR, anti-MTOR, anti-p-AKT, anti-AKT, and anti-ACTB (loading control) antibodies. The relative target protein levels were determined by densitometry in His-GST, His-V, His-H and His-N pre-treated cells. (E) EECs were treated with si-control or si-NECTIN4 and infected with PPRV (MOI = 3) for 1.5 h. The cell samples were analyzed by immunoblotting with anti-LC3, anti-SQSTM1, anti-p-MTOR, anti-MTOR, anti-p-AKT, anti-AKT, anti-NECTIN4 and anti-ACTB (loading control) antibodies. The relative target protein levels in the siRNA-transfected cells were determined by densitometry. The data represent the mean ± SD of three independent experiments. Two-way ANOVA; **P < 0.01; ***P < 0.001; #P > 0.05.
Fig 3: PPRV-H binding to NECTIN4 triggers autophagy via AKT-MTOR dephosphorylation. (A) Co-IP assay results demonstrating that endogenous NECTIN4 binds to H-HA in transfected cells. EECs were transfected with pCDNA3.1-H-HA for 48 h and harvested. Cell lysates from transfected cells and untransfected control cells were immunoprecipitated with an antibody against HA and then subjected to immunoblotting. (B) Exogenous NECTIN4-Flag and H-HA coexpression in EECs. Cell lysates from cells co-transfected with NECTIN4-Flag and H-HA or transfected with NECTIN4-Flag alone were immunoprecipitated with an antibody against HA and then subjected to immunoblotting. (C) Results of reciprocal co-IP experiments showing that the anti-Flag antibody precipitated H-HA. (D) EECs were transfected with pCDNA3.1-NECTIN4-Flag for 48 h and then infected with PPRV (MOI = 3) for 1.5 or 3 h. Cell lysates from the transfected cells were immunoprecipitated with an antibody against Flag and then subjected to immunoblotting. (E) EECs were transfected with pCDNA3.1-NECTIN4-Flag for 48 h and then incubated with 100 ng/mL His-GST, His-V, His-H, or His-N for 1.5 h. Cell lysates from the transfected cells were immunoprecipitated with an antibody against Flag and then subjected to immunoblotting. (F) Immunoblotting was performed using anti-LC3 and anti-SQSTM1 antibodies on lysates from EECs cultured in uncoated plates or in plates coated with anti-NECTIN4 or an irrelevant isotype control IgG for 4 h at 37°C. The target protein levels relative to the ACTB levels in cells pre-treated with anti-NECTIN4 or an irrelevant isotype control IgG were determined by densitometry. (G) EECs were transfected with GFP-LC3 for 24 h and cultured in plates coated with the irrelevant isotype control IgG or anti-NECTIN4 for 4 h. Autophagy was monitored by evaluating the number of GFP+-LC3 vesicles per cell profile by confocal immunofluorescence microscopy. Scale bars, 20 μm. The corresponding graph shows the number of GFP+-LC3 vesicles per cell profile among the EECs pre-treated with anti-NECTIN4 or the irrelevant isotype control IgG. (H) EECs were incubated with His-GST, a mixture of His-GST and NECTIN4 (His-GST:NECTIN4 = 1:3), a mixture of His-H and NECTIN4 (His-H:NECTIN4 = 1:3), or His-H for 1.5 h and analyzed by immunoblotting with anti-p-MTOR, anti-MTOR, anti-p-AKT, anti-AKT, anti-LC3, and anti-ACTB (loading control) antibodies. The relative target protein levels in the pre-treated cells were determined by densitometry. (I) EECs were incubated with His-GST (100 ng/mL) or His-H (100 ng/mL) and PPRV for 1.5 h at 37°C or 4°C. The cells were analyzed by immunoblotting with anti-p-MTOR, anti-MTOR, anti-p-AKT, anti-AKT, anti-LC3, and anti-ACTB (loading control) antibodies. The relative target protein levels in the pre-treated cells were determined by densitometry. The data represent the mean ± SD of three independent experiments. Two-way ANOVA; **P < 0.01; ***P < 0.001; #P > 0.05.
Fig 4: The protein staining of the peripheral villi of the placenta for the 22 markers evaluated by immunohistochemistry. VT: villous trophoblasts (primarily the syncytiotrophoblast), VSC: villous stromal cells, FBV: fetal blood vessel. Proteins significantly expressed in VT: CK7, CNR1, FERMT2, FLT1, PRTG, PVRL4, RXFP1, and UCHL1.
Fig 5: The protein staining of the interstitial extravillous trophoblasts of the basal plate and basal decidua for the 22 markers evaluated by immunohistochemistry. DSC: decidual stromal cells, iEVT: interstitial extravillous trophoblasts. Proteins significantly expressed in iEVT: AQPEP, CK7, CNR1, FERMT2, FLT1, GPX8, PRTG, PVRL4, THY1, and UCHL1.
Supplier Page from Abcam for Anti-Nectin-4 antibody